2012
DOI: 10.12659/msm.882460
|View full text |Cite
|
Sign up to set email alerts
|

Changes in chemiluminescence of whole blood of COPD patients treated with Hypoxen® and effects of C60 fullerenes on blood chemiluminescence

Abstract: SummaryBackgroundChronic obstructive pulmonary disease (COPD) is an inflammatory disease associated with reactive oxygen species (ROS) production. The aim of this study was to evaluate the effect of Hypoxen® treatment and the effect of HyFnC60 on ROS production in patients’ blood.Material/MethodsROS production in blood was estimated using chemiluminescence (CL) measurement with CL-amplifiers: luminol (LM), LM + zymosan (ZM) or lucigenin (LC) in the presence or absence of hydrated fullerenes (HyFnC60) added to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
11
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 12 publications
1
11
0
Order By: Relevance
“…Hypoxen ® treatment of COPD patients resulted in signi icant alternation of LM-ZM-dependent and LC-dependent CL of whole blood of patients. This is consistent with the claimed strong antioxidant activity of Hypoxen ® [9].…”
Section: Resultssupporting
confidence: 91%
See 1 more Smart Citation
“…Hypoxen ® treatment of COPD patients resulted in signi icant alternation of LM-ZM-dependent and LC-dependent CL of whole blood of patients. This is consistent with the claimed strong antioxidant activity of Hypoxen ® [9].…”
Section: Resultssupporting
confidence: 91%
“…We obtained the dependence of LM and lucigenin (LC) ampli ied CL of a healthy donor's blood in the upon them depended on blood state. Using the discriminator analysis we found the most important time points in the kinetic curves of CL for classi ication patients into groups (e.g., COPD patients before and after treatment with Hypoxen ® ) [9].…”
Section: Chronic Obstructive Pulmonary Disease (Copd) and Patients' Bmentioning
confidence: 99%
“…Additional experiments under similar conditions should be performed to confirm this suggestion. Previously [61,62,63,64], the biological activity of hydrated C 60 fullerene was studied and its activity was attributed to specific structure of hydrated shell of the fullerene.…”
Section: Resultsmentioning
confidence: 99%
“…Transient or long-term administration of the p38α inhibitor SB681323 significantly decreased the levels of p-HSP27 and TNF-α in whole blood and sputum neutrophils, indicating a remarkable reduction of airway inflammation [ 17 , 42 – 44 ] in patients with COPD. These studies suggest the pivotal role of p38 MAPK in the induction of airway inflammation in COPD patients, probably through CXCL8 signaling [ 6 , 45 , 46 ].…”
Section: Discussionmentioning
confidence: 99%